16-67230224-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_013241.3(FHOD1):āc.3056A>Gā(p.Glu1019Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,613,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_013241.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHOD1 | ENST00000258201.9 | c.3056A>G | p.Glu1019Gly | missense_variant | 20/22 | 1 | NM_013241.3 | ENSP00000258201.4 | ||
FHOD1 | ENST00000567752.5 | n.3637A>G | non_coding_transcript_exon_variant | 18/20 | 2 | |||||
FHOD1 | ENST00000569085.1 | n.-28A>G | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 250238Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135478
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461628Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727098
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2024 | The c.3056A>G (p.E1019G) alteration is located in exon 20 (coding exon 20) of the FHOD1 gene. This alteration results from a A to G substitution at nucleotide position 3056, causing the glutamic acid (E) at amino acid position 1019 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at